Skip to content
10-K

Annual Report

AlerisLife Inc.

0001159281-22-000026

← back to feed
Filed
Feb 24, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Feb 21, 2022 32.62M sh
Shares Diluted FY 2021 · Dec 31, 2021 31.59M sh
Shares Diluted FY 2021 · Dec 31, 2020 31.47M sh
Capex FY 2021 · Dec 31, 2021 $9.44M
Capex FY 2021 · Dec 31, 2020 $5.43M
Operating Cash Flow FY 2021 · Dec 31, 2021 −$7.57M
Operating Cash Flow FY 2021 · Dec 31, 2020 $51.38M
Cash And Equivalents FY 2021 · Dec 31, 2021 $66.99M
Cash And Equivalents FY 2021 · Dec 31, 2020 $84.35M
Stockholders Equity FY 2021 · Dec 31, 2021 $181.59M
Stockholders Equity FY 2021 · Dec 31, 2020 $210.53M
Stockholders Equity FY 2021 · Dec 31, 2019 $119.98M
Current Liabilities FY 2021 · Dec 31, 2021 $140.91M
Current Liabilities FY 2021 · Dec 31, 2020 $177.91M
Current Assets FY 2021 · Dec 31, 2021 $186.83M
Current Assets FY 2021 · Dec 31, 2020 $262.31M
Total Assets FY 2021 · Dec 31, 2021 $376.28M
Total Assets FY 2021 · Dec 31, 2020 $454.21M
Eps Diluted FY 2021 · Dec 31, 2021 −$0.95
Eps Diluted FY 2021 · Dec 31, 2020 −$0.24
Eps Basic FY 2021 · Dec 31, 2021 −$0.95
Eps Basic FY 2021 · Dec 31, 2020 −$0.24
Sga Expense FY 2021 · Dec 31, 2021 $85.72M
Sga Expense restated FY 2021 · Dec 31, 2020 $85.84M
Net Income FY 2021 · Dec 31, 2021 −$29.93M
Net Income FY 2021 · Dec 31, 2020 −$7.59M
Operating Income FY 2021 · Dec 31, 2021 −$25.86M
Operating Income FY 2021 · Dec 31, 2020 $15.94M